CHI Logo
Shop
Checkout
Header Graphic
March 20, 2010
| Insight Pharma Reports > Therapeutic Pipelines And Disease Markets

Add to Del.icio.us Add to digg Add to Connotea Add to Facebook Add to LinkedIn Add to Twitter EMail Page Printer Friendly Book Mark

Therapeutic Pipelines & Disease Markets

Combination Drug/Diagnostic Products and Other Applications of Personalized Medicine-Strategic Issues Facing Companies in this Market
March 2010
Table of Contents | Executive Summary

Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
January 2010
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
December 2009
Table of Contents | Tables and Figures | Executive Summary

Immunotherapies and Vaccines for Nontraditional Indications
October 2009
Table of Contents | Tables and Figures | Executive Summary

Ion Channel Modulator Pipelines
September 2009
Table of Contents | Tables and Figures | Executive Summary

Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
August 2009
Table of Contents | Tables and Figures | Executive Summary

Protease Inhibitors: Innovation Drives Drug Pipeline
February 2009
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutics Insight Update 2 (August 2008 - September 2008)
October 2008
Immunotherapies and Vaccines for Cancer and Infectious Diseases
October 2008
Table of Contents | Tables and Figures | Executive Summary

GPCRs: Dawn of a New Era?
October 2008
Table of Contents | Tables and Figures | Executive Summary

Obesity Drug Pipeline: Developing Therapies for a Complex Disease
September 2008
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutics Insight Update 1 (April 2008 - July 2008)
August 2008
Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
July 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008
Table of Contents | Tables and Figures | Executive Summary

Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
January 2008
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007
Table of Contents | Tables and Figures | Executive Summary

Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007
Table of Contents | Tables and Figures | Executive Summary

Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
February 2007
Table of Contents | Tables and Figures | Executive Summary

Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
November 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Infectious Diseases: R&D Challenges and Market Drivers
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Antiviral Therapeutics: Pipelines and Competitive Dynamics
July 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD
June 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market
May 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Oncogenomics: The Future of Cancer Cure
January 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

RNAi Therapeutics: Challenges in Drug Development and Delivery
November 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Hematological Cancer Therapeutics: Pipelines and Competition
October 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Development
August 2005
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Disease Therapeutics: Pipelines
June 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
March 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Metabolic Syndrome: Pipeline Analysis/Forecast
January 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cambridge Healthtech Institute

Footer Image
Loading...
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com